171 related articles for article (PubMed ID: 19786873)
1. Primetime for antiangiogenic therapy.
Tabatabai G; Stupp R
Curr Opin Neurol; 2009 Dec; 22(6):639-44. PubMed ID: 19786873
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic therapy in malignant gliomas.
Norden AD; Drappatz J; Wen PY
Curr Opin Oncol; 2008 Nov; 20(6):652-61. PubMed ID: 18841047
[TBL] [Abstract][Full Text] [Related]
3. Emerging antiangiogenic treatments for gliomas - efficacy and safety issues.
Dietrich J; Norden AD; Wen PY
Curr Opin Neurol; 2008 Dec; 21(6):736-44. PubMed ID: 19060566
[TBL] [Abstract][Full Text] [Related]
4. Treatment of recurrent high-grade gliomas.
Wen PY; Brandes AA
Curr Opin Neurol; 2009 Dec; 22(6):657-64. PubMed ID: 19770658
[TBL] [Abstract][Full Text] [Related]
5. Novel anti-angiogenic therapies for malignant gliomas.
Norden AD; Drappatz J; Wen PY
Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction inhibitors and antiangiogenic therapies for malignant glioma.
Mellinghoff IK; Lassman AB; Wen PY
Glia; 2011 Aug; 59(8):1205-12. PubMed ID: 21351155
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic therapy in malignant glioma: promise and challenge.
Sathornsumetee S; Rich JN
Curr Pharm Des; 2007; 13(35):3545-58. PubMed ID: 18220791
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiogenesis and invasion in malignant gliomas.
Chi A; Norden AD; Wen PY
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic therapy for high-grade gliomas: current concepts and limitations.
De Bonis P; Marziali G; Vigo V; Peraio S; Pompucci A; Anile C; Mangiola A
Expert Rev Neurother; 2013 Nov; 13(11):1263-70. PubMed ID: 24175724
[TBL] [Abstract][Full Text] [Related]
10. Evolving strategies: future treatment of glioblastoma.
Chamberlain M
Expert Rev Neurother; 2011 Apr; 11(4):519-32. PubMed ID: 21469925
[TBL] [Abstract][Full Text] [Related]
11. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
12. Angiogenic inhibition in high-grade gliomas: past, present and future.
Jo J; Schiff D; Purow B
Expert Rev Neurother; 2012 Jun; 12(6):733-47. PubMed ID: 22650175
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in malignant glioma--a target for antitumor therapy?
Tuettenberg J; Friedel C; Vajkoczy P
Crit Rev Oncol Hematol; 2006 Sep; 59(3):181-93. PubMed ID: 16860996
[TBL] [Abstract][Full Text] [Related]
14. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
15. Editorial review: targets for glioma treatment: from bench to bedside.
Sanson M
Curr Opin Oncol; 2008 Nov; 20(6):650-1. PubMed ID: 18841046
[TBL] [Abstract][Full Text] [Related]
16. New treatment strategies for malignant gliomas.
Sathornsumetee S; Rich JN
Expert Rev Anticancer Ther; 2006 Jul; 6(7):1087-104. PubMed ID: 16831080
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal brain imaging of five malignant glioma patients treated with bevacizumab using susceptibility-weighted magnetic resonance imaging at 7 T.
Grabner G; Nöbauer I; Elandt K; Kronnerwetter C; Woehrer A; Marosi C; Prayer D; Trattnig S; Preusser M
Magn Reson Imaging; 2012 Jan; 30(1):139-47. PubMed ID: 21982163
[TBL] [Abstract][Full Text] [Related]
18. Current status of antiangiogenic therapies for glioblastomas.
Arrillaga-Romany I; Reardon DA; Wen PY
Expert Opin Investig Drugs; 2014 Feb; 23(2):199-210. PubMed ID: 24320142
[TBL] [Abstract][Full Text] [Related]
19. Editorial: what is new in the treatment of gliomas?
Omuro AM; Delattre JY
Curr Opin Neurol; 2007 Dec; 20(6):704-7. PubMed ID: 17992093
[TBL] [Abstract][Full Text] [Related]
20. Small molecule inhibitors in children with malignant gliomas.
Herrington B; Kieran MW
Pediatr Blood Cancer; 2009 Sep; 53(3):312-7. PubMed ID: 19434732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
